Gene‑expression Signature Predicts Survival Benefit From Postoperative Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma

Oncology Letters - Greece
doi 10.3892/ol.2018.8964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

PD-L1 Expression Predicts Longer Disease Free Survival in High Risk Head and Neck Cutaneous Squamous Cell Carcinoma

Pathology
Forensic MedicinePathology
2017English

MRI Texture Analysis Predicts P53 Status in Head and Neck Squamous Cell Carcinoma

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2014English

SOX2 Activation Predicts Prognosis in Patients With Head and Neck Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2018English

A Three-Long Non-Coding RNA Signature Derived From the Cancer Genome Atlas Database Predicts the Survival of Patients With Head and Neck Squamous Cell Carcinoma

International Journal of Oral and Maxillofacial Surgery
OtorhinolaryngologyOral SurgerySurgery
2017English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Intratumor Heterogeneity of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2019English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy